Iproclozide
| Iproclozide | |
|---|---|
| INN | |
| Drug class | Monoamine oxidase inhibitor |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 3544-35-2 |
| PubChem | 71884 |
| DrugBank | DB08991 |
| ChemSpider | 64878 |
| KEGG | D04210 |
Iproclozide is a monoamine oxidase inhibitor (MAOI) that was used as an antidepressant in the treatment of depression. It belongs to the class of hydrazine derivatives.
Mechanism of Action[edit]
Iproclozide works by inhibiting the activity of the enzyme monoamine oxidase (MAO). This enzyme is responsible for breaking down monoamine neurotransmitters such as serotonin, norepinephrine, and dopamine. By inhibiting MAO, iproclozide increases the levels of these neurotransmitters in the brain, which can help alleviate symptoms of depression.
Clinical Use[edit]
Iproclozide was primarily used in the treatment of major depressive disorder. However, due to the risk of severe side effects and the development of safer antidepressants, its use has declined.
Side Effects[edit]
The use of iproclozide can lead to several side effects, including:
- Hypertensive crisis (especially when taken with tyramine-rich foods)
- Orthostatic hypotension
- Insomnia
- Weight gain
- Sexual dysfunction
Interactions[edit]
Iproclozide can interact with various substances, leading to potentially dangerous effects. Notable interactions include:
- Tyramine-rich foods (e.g., aged cheese, cured meats)
- Other antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
- Sympathomimetic drugs
Withdrawal and Discontinuation[edit]
Abrupt discontinuation of iproclozide can lead to withdrawal symptoms, including:
History[edit]
Iproclozide was developed and introduced in the mid-20th century. It was one of the earlier MAOIs used for the treatment of depression. However, due to its side effect profile and the advent of newer antidepressants, its use has significantly decreased.
See Also[edit]
- Monoamine oxidase inhibitor
- Antidepressant
- Major depressive disorder
- Serotonin
- Norepinephrine
- Dopamine
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
